Physician profile
Jayram Krishnan
NPI 1245216605
$86,678.70
in general payments reported to CMS, 2019-2025
27 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,888 · 2020: $9,423 · 2021: $6,881 · 2022: $17K · 2023: $7,656 · 2024: $20K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Travel and Lodging: $9,529 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,875 · Consulting Fee: $5,942 · Food and Beverage: $5,814 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18,568.00 |
| Travel and Lodging | $9,528.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,875.00 |
| Consulting Fee | $5,942.00 |
| Food and Beverage | $5,813.75 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,263.56 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Astellas Pharma US INC | $17,118.40 | 2019-2025 | Xtandi, Padcev |
| Myovant Sciences INC. | $10,159.03 | 2021-2022 | |
| Photocure INC | $6,498.43 | 2019-2025 | Cysview |
| Janssen Biotech, INC. | $5,507.33 | 2024-2025 | Rybrevant, Carvykti, Erleada |
| Janssen Scientific Affairs, LLC | $3,017.60 | 2024-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $2,981.84 | 2024-2025 | Adstiladrin |
| Conmed Corporation | $2,639.92 | 2019-2024 | Airseal |
| Teleflex LLC | $1,403.73 | 2024-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $962.66 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit |
| Pfizer INC. | $312.20 | 2020 | |
| Procept Biorobotics Corporation | $306.54 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $278.13 | 2023-2024 | Orgovyx, Gemtesa |
| Biotissue Holdings INC. | $234.77 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $214.67 | 2024-2025 | Keytruda |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $154.91 | 2025 | Restrata Wound Matrix |
| Calyxo, INC. | $148.71 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $138.53 | 2022-2025 | Xyosted |
| Neotract INC. | $96.67 | 2019 | |
| Bioprotect Medical, INC. | $84.39 | 2025 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $37.27 | 2025 | Provenge |
| Mimedx Group, INC. | $29.95 | 2025 | |
| Progenics Pharmaceuticals, INC. | $20.93 | 2023 | Pylarify |
| Karl Storz Endoscopy-America | $19.20 | 2020 | |
| 180 Medical, INC. | $17.31 | 2025 | |
| Abbott Laboratories | $17.30 | 2025 | Alinity |
| Tempus Ai, INC | $14.72 | 2025 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayram Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.